Cross Staff Investments Inc Has $316,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cross Staff Investments Inc boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 936 shares of the medical equipment provider’s stock after purchasing an additional 36 shares during the quarter. Cross Staff Investments Inc’s holdings in Intuitive Surgical were worth $316,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its stake in shares of Intuitive Surgical by 0.3% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock worth $3,002,000 after buying an additional 27 shares during the last quarter. Liberty Capital Management Inc. increased its holdings in Intuitive Surgical by 3.8% in the fourth quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 30 shares during the last quarter. Miracle Mile Advisors LLC grew its position in shares of Intuitive Surgical by 2.3% during the 4th quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider’s stock worth $485,000 after buying an additional 32 shares during the period. Ausdal Financial Partners Inc. boosted its stake in Intuitive Surgical by 1.5% during the 4th quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider’s stock worth $739,000 after acquiring an additional 33 shares during the last quarter. Finally, Venturi Wealth Management LLC raised its holdings in Intuitive Surgical by 10.7% in the fourth quarter. Venturi Wealth Management LLC now owns 341 shares of the medical equipment provider’s stock worth $115,000 after purchasing an additional 33 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 24,325 shares of Intuitive Surgical stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the sale, the chief executive officer now directly owns 9,425 shares in the company, valued at approximately $3,544,365.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total value of $1,971,169.88. Following the completion of the transaction, the executive vice president now directly owns 298 shares of the company’s stock, valued at approximately $110,456.68. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Gary S. Guthart sold 24,325 shares of the firm’s stock in a transaction on Monday, January 29th. The stock was sold at an average price of $376.06, for a total value of $9,147,659.50. Following the completion of the transaction, the chief executive officer now directly owns 9,425 shares of the company’s stock, valued at $3,544,365.50. The disclosure for this sale can be found here. Insiders sold a total of 249,418 shares of company stock valued at $96,300,959 in the last quarter. Insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on ISRG shares. Wells Fargo & Company raised their price target on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research report on Friday, January 19th. Barclays upped their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Finally, Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $396.17.

Intuitive Surgical Price Performance

ISRG stock traded up $4.22 during midday trading on Friday, reaching $377.34. The company had a trading volume of 524,382 shares, compared to its average volume of 1,653,088. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $403.76. The company has a market capitalization of $133.85 billion, a price-to-earnings ratio of 67.94, a price-to-earnings-growth ratio of 4.84 and a beta of 1.36. The stock has a 50 day moving average price of $386.26 and a 200-day moving average price of $345.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. Intuitive Surgical’s revenue was up 11.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.00 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.